Research Grade · 99%+ Purity · COA Verified

Retatrutide represents the absolute cutting edge of metabolic research. It is a synthetic, single-peptide chain that functions as a revolutionary triple hormone receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. Often referred to in clinical literature as "3G," Retatrutide sets a new standard for investigation into advanced weight modeling, intensive glycemic control, and metabolic pathway optimization.

Key Research Focus Areas:

• Triple-Receptor Pathway Synergy: Simultaneously engages GLP-1 (appetite suppression and gastric emptying), GIP (fat cell management and insulin sensitivity), and Glucagon (direct lipolysis and increased energy expenditure) for unmatched metabolic modulation.

• Aggressive Adipose Tissue Breakdown: The inclusion of the glucagon pathway allows researchers to observe direct fat oxidation and metabolic rate increases, differentiating it from traditional dual-agonist models.

• Advanced Insulin & Glycemic Modeling: Extensively studied for its profound, multi-angled capability to restore healthy glucose homeostasis and enhance pancreatic beta-cell responsiveness.

• Appetite Regulation Signals: Interacts directly with hypothalamic receptors to profoundly modulate satiety signaling and curb metabolic cravings at the central nervous system level.

Product Specifications:

• Purity: >99% verified via HPLC & Mass Spectrometry testing.

• Format: Lyophilized (freeze-dried) powder for maximum molecular stability.

• Storage: Store dry at -20°C for long-term preservation; keep refrigerated at 2°C–8°C after reconstitution.

⚠️ Research Disclaimer

This product is sold strictly as a lyophilized peptide for laboratory research and in vitro testing purposes only. It is not approved for human consumption, therapeutic, or diagnostic use.  For research use only.